Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

RBMY1A1 Rabbit anti-Human, Polyclonal, Invitrogen™

Rabbit Polyclonal Antibody

Manufacturer:  Invitrogen PA522074

Catalog No. PIPA522074


Add to cart

Description

Description

PA5-22074 targets RBMY1A1 in WB applications and shows reactivity with Human samples. The PA5-22074 immunogen is a recombit fragment corresponding to a region within amino acids 1 and 241 of RBMY1A1 (Uniprot IDNo.Q15414). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial. For short-term storage (1-2 weeks), product can be stored at 4°C. For long-term storage, aliquot and store product at -20° C or below, avioiding multiple freeze-thaw cycles.

Specifications

Specifications

RBMY1A1
Polyclonal
Unconjugated
RBMY1A1
Liquid
RBMY1A1
Recombit fragment corresponding to a region within amino acids 1 and 241 of RBMY1A1 (Uniprot IDNo.Q15414)
Antigen affinity chromatography
RUO
Antibody
Polyclonal
Human
Western Blot
0.93 mg/mL
0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7
P0DJD3
RBM, RBM1, RBM2, RBMY, RBMY1C, YRRM1, YRRM2, RNA binding motif protein, Y chromosome, family 1, member A1, RNA binding protein, RNA-binding motif protein 1, RNA-binding motif protein 2, RNA-binding motif protein, Y chromosome, family 1 member A1/C, y chromosome RNA recognition motif 1
Rabbit
IgG
100 μL
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Primary
5940
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit